Kirk Redger, MD
Urology · Aurora, CONPI 1548689052
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by SWAN Valley Medical Incorporated at 40.7% of the total. Reporting peaked in 2022 at $11,298 and has fallen 50.5% since, to $5,596 in 2025. Among urology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $160.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SWAN Valley Medical Incorporated$10K
- Boston Scientific$5K
- Intuitive Surgical$3K
- Uromedica, Incorporated$3K
- Valencia Technologies Corporation$816
- Coloplast$550
- plus $2K from 21 others
Across 3 payments — averaging $0.00 each. An ownership or investment interest held by the physician or an immediate family member.
- SWAN Valley Medical Incorporated$0
What the payments were for
- Consulting fees$9,50039%
- Speaking & faculty fees$3,29414%
- Travel & lodging$4,04117%
- Food & beverage$5,85424%
- Education$1,5006%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SWAN Valley Medical Incorporated | 4 | $9,842 |
| Boston Scientific | 59 | $5,007 |
| Intuitive Surgical | 14 | $3,431 |
| Uromedica, Incorporated | 1 | $2,500 |
| Valencia Technologies Corporation | 2 | $816 |
| Coloplast | 12 | $550 |
| Medtronic | 11 | $507 |
| Axonics, Inc. | 8 | $465 |
| AbbVie | 12 | $188 |
| Innovation Technologies Inc | 2 | $160 |
| Caldera Medical, Inc | 1 | $134 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| LSI Solutions Inc | 1 | $61 |
| Integra Lifesciences Corporation | 3 | $58 |
| Convatec Inc. | 2 | $57 |
| Johnson & Johnson(2 entities) | 2 | $55 |
| Pfizer | 2 | $45 |
| Olympus America Inc. | 2 | $37 |
| Procept Biorobotics Corporation | 2 | $36 |
| Calyxo, Inc. | 1 | $30 |
| Urogen Pharma, Inc. | 1 | $29 |
| Merck | 1 | $25 |
| Urgo Medical North America, LLC | 1 | $23 |
| Progenics Pharmaceuticals, Inc. | 1 | $20 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $16 |
| KCI USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ProACT$2,500
- Da Vinci Surgical System$1,730
- DA VINCI SP$1,500
- AdVance XP$788
- eCoin Device Kit$762
- GENERAL ERECTILE DYSFUNCTION$588
- AMS 700 CXR RTE KIT$503
- AMS 700$397
- INTERSTIM$308
- Axonics$249
- Bulkamid$249
- GENERAL MALE SUI$137
- Desara$134
- Irrisept$123
- GENERAL PELVIC ORGAN PROLAPSE$120
- TITAN$111
- VIRTUE$106
How this compares
$24,189 in reported general payments places this provider in the 90th percentile of 225 urology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 51 | $33,823 |
| GemtesaVibegron | 46 | $24,324 |
| Methenamine Hippurate | 21 | $2,022 |
| Tamsulosin Hcl | 100 | $1,515 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $517 |
| Finasteride | 19 | $251 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 78 | $223 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $77 |
| Cephalexin | 13 | $40 |
| Levofloxacin | 12 | $28 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $62 | $24,32446 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 225 urology providers in Colorado.
Other urology in Aurora
- Janet KukrejaAurora$39K
- David StraussAurora$16K
- Kerri ThurmonAurora$16K
- Brian FlynnAurora$12K
- Lawrence KarshDenver$706K
- Alexandra RogersLafayette$476K
- Derek ZukoskyGolden$442K
- James McBrideDurango$234K
- Damian SorceParker$224K
- Suzanne MerrillLone Tree$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.